NZX/ASX Market Release
Overview – financial results for the 6 months ended 31 December 2015 (NZ$m)
- Total revenue of $139.1 million, an increase of 86% over the prior corresponding period (pcp)
- Substantial growth in sales of a2 Platinum® infant formula across Australia and New Zealand (ANZ) and China with total revenue of $73.9 million, up 340% on pcp. This compares with previously advised sales for the four months to 31 October 2015 of $38.0 million
- Net profit after tax of $10.1 million, compared to $0.1 million in pcp
- Group operating EBITDA of $18.7 million, representing a 472% increase on pcp. This result includes expensing establishment costs in the USA and UK markets of $8.1 million, record operating performance in ANZ and significant growth in China
- Increased fresh milk performance in Australia with sales up 5% in AUD over the pcp
- Accordingly, the full year forecast has been revised upward with Group revenue in the range of $335 million to $350 million and Group operating EBITDA forecast to be in the range of $45 million to $49 million
To view the half year 2016 results commentary, please click here
To view the half year 2016 results presentation, please click here
To view the half year 2016 results report, please click here
To view the preliminary half year 2016 report announcement, please click here
To view the NZX results, please click here
To view the ASX Appendix 4D, please click here
View a selection of media coverage from around the world
Sky News Business interview with Geoffrey Babidge, CEO:
Press articles:
